Hyderabad-based SCIINV Biosciences has identified a new AI-driven repurposed antibiotic now entering human clinical trials. The breakthrough, backed by Whale Tank Biocatalyst, reduces development time and offers hope in combating antimicrobial resistance amid a stagnating global antibiotic pipeline.
On the occasion, the company also demonstrated its latest AI-powered digital platform and solutions (Zyrix, KiTAP and DQ Gateway) developed by its innovation team in Hyderabad
